AVE5026 for the prevention of VTE in acutely ill patients

• Research type

  Research Study

• Full title

  A Multinational, Multicenter, Randomized, Double-Blind Study Comparing the Efficacy and Safety of AVE5026 with enoxaparin for the Primary Prevention of Venous Thromboembolism in Acutely Ill Medical Patients with Restricted Mobility

• Contact name

  Charles McCollum

• Contact email

  cnmcc@manchester.ac.uk

• Sponsor organisation

  Sanofi Aventis

• Eudract number

  2008-000228-13

• REC name

  East of England - Cambridgeshire and Hertfordshire Research Ethics Committee

• REC reference

  08/H0311/119

• Date of REC Opinion

  21 Oct 2008

• REC opinion

  Further Information Favourable Opinion